Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis

Smith, SL, Alexander, S, Nair, N et al. (8 more authors) (2023) Pre-treatment calprotectin (MRP8/14) provides no added value to testing CRP alone in terms of predicting response to TNF inhibitors in rheumatoid arthritis in a post hoc analysis. Annals of the Rheumatic Diseases, 82 (5). pp. 611-620. ISSN 0003-4967

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© Author(s) (or their employer(s)) 2023. This is an open access article under the terms of the Creative Commons Attribution License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.

Dates:
  • Published: 18 October 2023
  • Published (online): 21 February 2023
  • Accepted: 12 January 2023
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM) > Discovery & Translational Science Dept (Leeds)
Funding Information:
Funder
Grant number
MRC (Medical Research Council)
R116825
NIHR National Inst Health Research
NIHR202395
Depositing User: Symplectic Publications
Date Deposited: 10 Mar 2023 10:43
Last Modified: 14 Nov 2024 09:26
Status: Published
Publisher: BMJ
Identification Number: 10.1136/ard-2022-222519
Related URLs:
Open Archives Initiative ID (OAI ID):

Download

Export

Statistics